CoChat

Homozygosity of the autosomal dominant Alzheimer disease presenilin 1 E280A mutation

Open access
Kosik, Kenneth S., Muñoz, Claudia, Lopez, Liliana, Arcila, Mary Luz, García, Gloria, Madrigal, Lucía, Moreno, Sonia, Ríos Romenets, Silvia, Lopez, Hugo, Gutierrez, Madelyn, Langbaum, Jessica B., Cho, William, Suliman, Shehnaaz, Tariot, Pierre N., Ho, Carole, Reiman, Eric M., Lopera, Francisco · 2015 · Neurology
Cited by 20

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

We identified several families in Antioquia, Colombia, with early-onset Alzheimer disease (AD) due to the mendelian autosomal dominant inheritance of a PSEN1 E280A gene mutation. Extended family members were interviewed and parish baptism certificates in Antioquian municipalities examined.1 The size of these extended families (including carriers and noncarriers) approaches 5,000 individuals. Full genomes in carriers proved a single founder.2 To support an AD prevention clinical trial, we established a registry in 2010 of all family members over age 8 years.3 Since then we genotyped 3,407 family members and identified 823 (24%) carriers of the PSEN1 E280A mutation. The Comite de Bioetica de la Sede de Investigacion Universitaria, SIU Universidad de Antioquia, approved this study. All participants provided written informed consent. Despite the size of this exceptionally large family and frequent consanguinity, homozygosity at this gene locus had not been reported. The apparent absence of homozygous PSEN1 mutations led to the speculation that E280A homozygosity could be lethal. Generally, homozygous dominant mutations are more severely affected than heterozygotes in both humans and model systems.4 However, human cases in which dominant point mutations are homozygous are rare.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1212/wnl.0000000000001130

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

See all 20

Metadata

Authors
Kosik, K. S., Muñoz, C., Lopez, L., Arcila, M. L., García, G., Madrigal, L., Moreno, S., Ríos Romenets, S., Lopez, H., Gutierrez, M., Langbaum, J. B., Cho, W., Suliman, S., Tariot, P. N., Ho, C., Reiman, E. M., & Lopera, F.
Venue
Neurology
Published
2015-01-13
Volume
84
Issue
2
Pages
206-208
ISSN
  • 0028-3878 (ISSN-L)
  • 1526-632X
OpenAlex
W2087244450
Cited by
20
References
3
FWCI
1.17
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Homozygosity of the autosomal dominant Alzheimer disease presenilin 1 E280A mutation. https://app.cochat.ai/papers/10.1212/wnl.0000000000001130
The paper
Kosik, K. S., Muñoz, C., Lopez, L., Arcila, M. L., García, G., Madrigal, L., Moreno, S., Ríos Romenets, S., Lopez, H., Gutierrez, M., Langbaum, J. B., Cho, W., Suliman, S., Tariot, P. N., Ho, C., Reiman, E. M., & Lopera, F. (2015). Homozygosity of the autosomal dominant Alzheimer disease presenilin 1 E280A mutation. Neurology. https://doi.org/10.1212/wnl.0000000000001130

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.